Glaukos (GKOS) Free Cash Flow (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -228.19% |
| Dec 31, 2025 | -384.59% |
| Sep 30, 2025 | 119.34% |
| Jun 30, 2025 | 52.03% |
| Mar 31, 2025 | -1,451.63% |
| Dec 31, 2024 | 88.89% |
| Sep 30, 2024 | 46.21% |
| Jun 30, 2024 | 41.10% |
| Mar 31, 2024 | -296.02% |
| Dec 31, 2023 | -774.10% |
| Sep 30, 2023 | 109.37% |
| Jun 30, 2023 | 63.03% |
| Mar 31, 2023 | -366.97% |
| Dec 31, 2022 | 143.35% |
| Sep 30, 2022 | -50.66% |
| Jun 30, 2022 | -781.61% |
| Mar 31, 2022 | 106.32% |
| Dec 31, 2021 | -213.85% |
| Sep 30, 2021 | 354.80% |
| Jun 30, 2021 | -5,343.33% |
| Mar 31, 2021 | -96.10% |
| Dec 31, 2020 | 177.96% |
| Sep 30, 2020 | 20.51% |
| Jun 30, 2020 | 1.66% |
| Mar 31, 2020 | -157.77% |
| Dec 31, 2019 | -34.79% |
| Sep 30, 2019 | -184.46% |
| Jun 30, 2019 | 1,167.72% |
| Mar 31, 2019 | -104.64% |
| Dec 31, 2018 | 162.61% |
| Sep 30, 2018 | 18.56% |
| Jun 30, 2018 | 139.83% |
| Mar 31, 2018 | -172.60% |
| Dec 31, 2017 | 130.07% |
| Sep 30, 2017 | 53.58% |
| Jun 30, 2017 | 91.63% |
| Mar 31, 2017 | 26.70% |
| Dec 31, 2016 | 35.53% |
| Sep 30, 2016 | -82.45% |
| Jun 30, 2016 | 495.51% |
| Mar 31, 2016 | -39.05% |
| Dec 31, 2015 | -27.70% |
| Sep 30, 2015 | 11.69% |
| Jun 30, 2015 | 18.88% |
| Mar 31, 2015 | 42.00% |
| Dec 31, 2014 | -144.31% |
| Sep 30, 2014 | -262.69% |